They have limited advantage against cccDNA, the seemingly indestructible “mini-chromosome” of the hepatitis B virus that continues to produce virus particles in infected liver cells, even in individuals being treated. A cure, therefore, would have to demolish or silence cccDNA and provide long-term protective immunity.